Datasets:

Fernandosr85
/

adaption-rit1-vus-research-tiers

prompt stringlengths 426 733	completion stringlengths 3.07k 5.42k	enhanced_prompt stringlengths 597 2.2k	enhanced_completion stringlengths 3.48k 7.54k
Explain the assigned active-investigation tier for RIT1 missense variant p.Thr163Ile. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 8/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Eviden...	Variant: RIT1 p.Thr163Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.986 (AlphaMissense ...	# Task: Explain the Active-Investigation Tier for RIT1 Variant Analyze the provided data for the RIT1 missense variant p.Thr163Ile and explain the rationale behind its assigned investigation tier. ## Critical Constraints - Preserve Values Exactly: You must include the following values verbatim in your respon...	### Variant Analysis: RIT1 p.Thr163Ile Variant: RIT1 p.Thr163Ile (small GTPase, UniProt Q92963) Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355). RIT1 is associated exclusively with NS8; there is no associated CFC syndrome or secondary RASopathy condition for this gene. ASSIGNED TIER: Tier 2 — stro...
Explain the source-derived research-prioritization assessment for RIT1 variant p.Phe82Leu in the context of Noonan Syndrome 8 (NS8, OMIM 615355). Assigned investigation tier: Tier 1 — highest priority. Investigation score: NA/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or ...	Variant: RIT1 p.Phe82Leu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Explain Source-Derived Research-Prioritization Assessment Provide a detailed explanation of the research-prioritization assessment for the RIT1 variant p.Phe82Leu within the context of Noonan Syndrome 8 (NS8, OMIM 615355). ## Critical Constraints - Assigned Investigation Tier: Tier 1 — highes...	# Variant Research Prioritization Assessment: RIT1 p.Phe82Leu ## Variant Identification and Condition Context - Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) - Variant: p.Phe82Leu - Protein: Small GTPase (219 aa) — the shortest protein in the RASopathy VUS series - Associated Condition: ...
Explain why RIT1 p.Asp87His was assigned to Tier 1 — highest priority. Investigation score: 11/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=32.0 (cadd_phred_final), AlphaMissense score=0.993, AlphaMissense model class=like...	Variant: RIT1 p.Asp87His (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 11/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.993 (AlphaMis...	# Task: Explain Tier 1 Assignment for RIT1 p.Asp87His Provide a detailed explanation of why the variant RIT1 p.Asp87His was assigned to Tier 1 (highest priority) with an Investigation score of 11/16. ## Constraints - Mandatory Preservation: You must include the following labels exactly as written, ver...	### Variant Prioritization Assessment: RIT1 p.Asp87His Variant: RIT1 p.Asp87His (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 1 — highest priority Investigation score: 11/16 --- #### Evidence Summary The assignment of RIT1 p.Asp87His to Tier 1 (highest priority) reflects convergence of high...
Given this RIT1 variant evidence profile — p.Ala77Gly, assigned tier Tier 1 — highest priority, investigation score 12/16, CADD PHRED 32.0 (cadd_phred_final), AlphaMissense score 0.973, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Ala77Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 12/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.973 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose any changes to it. Variant Evidence Profile: - Variant: p.Ala77Gly - Assigned Tier: Tier 1 (highest priority) - Investigation Score: 12/16...	Variant: RIT1 p.Ala77Gly (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 1 (highest priority) Investigation Score: 12/16 --- ### Evidence Summary The p.Ala77Gly variant presents a convergent evidence profile warranting highest-priority research investigation within the Noonan Syndrome 8 (NS8, OMIM 61...
Given this RIT1 variant evidence profile — p.Arg183Gly, assigned tier Tier 2 — strong priority, investigation score 10/16, CADD PHRED 33.0 (cadd_phred_final), AlphaMissense score 0.973, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Arg183Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: very high (PHRED 33.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.973 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose any changes to it. Variant Evidence Profile: - Variant: p.Arg183Gly - Assigned Tier: Tier 2 - Priority Level: Strong - **Investigation Sco...	Variant: RIT1 p.Arg183Gly (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 2 — strong priority Investigation score: 10/16 --- ### Evidence Summary and Research Prioritization Rationale The RIT1 variant p.Arg183Gly is designated Tier 2 — strong priority based on a convergence of high-impact computa...
Explain the assigned active-investigation tier for RIT1 missense variant p.Met90Ile. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 8/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Evidenc...	Variant: RIT1 p.Met90Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.2 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.971 (AlphaMissense m...	Explain the assigned active-investigation tier for the RIT1 missense variant p.Met90Ile based on the provided data. Constraints: - Preserve the following values exactly in your response: - Assigned investigation tier: Tier 2 — strong priority - Investigation score: 8/16 - Do not reclassify, upgrade, downgrad...	Variant Identification Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) Variant: p.Met90Ile Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355) Assigned investigation tier: Tier 2 — strong priority Investigation score: 8/16 --- Evidence Summary The prioritization of RIT1 ...
Given this RIT1 variant evidence profile — p.Ile102Thr, assigned tier Tier 3 — follow-up priority, investigation score 6/16, CADD PHRED 28.8 (cadd_phred_final), AlphaMissense score 0.932, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleter...	Variant: RIT1 p.Ile102Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 3 — follow-up priority Investigation score (source-derived, do not modify): 6/16 Evidence profile: - CADD PHRED: high (PHRED 28.8 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.932 (AlphaMissen...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier (Tier 3) without proposing a change. Variant Evidence Profile: - Variant: p.Ile102Thr - Assigned Tier: Tier 3 - Follow-up Priority: Investigation score 6/...	### Variant Evidence Profile: RIT1 p.Ile102Thr Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) - Protein Change: p.Ile102Thr - Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355) Evidence Summary The p.Ile102Thr variant presents with elevated computational...
A genetics research team is reviewing RIT1 p.Gly78Glu (small GTPase). Explain why this variant was assigned to Tier 1 — highest priority with investigation score NA/16. The assigned tier and score are source-derived labels and must be preserved verbatim. Summarize CADD PHRED=NA (cadd_phred_final), AlphaMissense score=N...	Variant: RIT1 p.Gly78Glu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Analyze RIT1 Variant Classification You are assisting a genetics research team reviewing the RIT1 p.Gly78Glu variant (a small GTPase). Please explain the rationale for assigning this variant to Tier 1 (highest priority) with an investigation score of NA/16. ## Constraints - **Verbatim Preservation...	# Variant Analysis: RIT1 p.Gly78Glu ## Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1) - Protein Change: p.Gly78Glu - Associated Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ## Assigned Classification and Scores - ASSIGNED TIER: Tier 1 - Investigation score: NA/16 ## Evid...
Explain why RIT1 p.Phe82Leu was assigned to Tier 1 — highest priority. Investigation score: 11/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=31.0 (cadd_phred_final), AlphaMissense score=1.000, AlphaMissense model class=like...	Variant: RIT1 p.Phe82Leu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 11/16 Evidence profile: - CADD PHRED: very high (PHRED 31.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 1.000 (AlphaMis...	# Task: Explain RIT1 Variant Tier Assignment Explain why the variant RIT1 p.Phe82Leu was assigned to Tier 1 (highest priority) with an Investigation score of 11/16. ### Constraints - Verbatim Preservation: You must preserve the assigned tier and score labels exactly as provided: "Tier 1" and "Investig...	### Variant Assessment: RIT1 p.Phe82Leu Variant: RIT1 p.Phe82Leu (small GTPase, 219 aa, UniProt Q92963) ASSIGNED TIER: Tier 1 Investigation score: 11/16 --- #### Evidence Summary The prioritization of p.Phe82Leu as Tier 1 is supported by convergence of high-impact computational predictions, absolute pop...
Explain the assigned active-investigation tier for RIT1 missense variant p.Met90Thr. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 9/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Evidenc...	Variant: RIT1 p.Met90Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 9/16 Evidence profile: - CADD PHRED: high (PHRED 28.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.996 (AlphaMissense m...	# Task: Explain the Assigned Active-Investigation Tier Analyze the provided data for the RIT1 missense variant p.Met90Thr and explain the rationale behind its assigned investigation tier. ## Critical Constraints - Preserve Values Exactly: You must include the specific tier and score values provided below ver...	### Variant Investigation Report: RIT1 p.Met90Thr Variant: RIT1 missense variant p.Met90Thr ASSIGNED TIER: Tier 2 — strong priority Investigation Score: 9/16 --- ## Evidence Summary The assignment of Tier 2 — strong priority with an Investigation Score: 9/16 reflects a convergence of computa...
Explain why RIT1 p.Asp87Asn was assigned to Tier 2 — strong priority. Investigation score: 10/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=32.0 (cadd_phred_final), AlphaMissense score=0.975, AlphaMissense model class=likel...	Variant: RIT1 p.Asp87Asn (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.975 (AlphaMiss...	# Task: Explain Variant Tier Assignment Explain why the variant RIT1 p.Asp87Asn was assigned to Tier 2 — strong priority with an Investigation score: 10/16. ## Critical Constraints - The assigned tier ("Tier 2 — strong priority") and score ("10/16") are source-derived pipeline labels. You must preserv...	### Variant Tier Assignment Explanation: RIT1 p.Asp87Asn Variant: RIT1 p.Asp87Asn ASSIGNED TIER: Tier 2 — strong priority Investigation score: 10/16 --- #### Evidence Summary The assignment of Tier 2 — strong priority with an Investigation score: 10/16 is based on the convergence of high-imp...
For RIT1 p.Glu81Gly (small GTPase, NS8), write a research-level variant assessment. The assigned tier is Tier 1 — highest priority and the investigation score is NA/16. Preserve both exactly. Do not make a clinical classification. Include computational deleteriousness, population rarity, structural context within the R...	Variant: RIT1 p.Glu81Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Research-Level Variant Assessment Generate a research-level assessment for the variant RIT1 p.Glu81Gly associated with NS8 (Noonan Syndrome 8, OMIM 615355). Note that RIT1 encodes a small GTPase and causes only NS8. ## Mandatory Constraints - Assigned Tier: Tier 1 — highest priority (Preserve this...	# Research-Level Variant Assessment: RIT1 p.Glu81Gly Variant: RIT1 p.Glu81Gly Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ASSIGNED TIER: Tier 1 — highest priority Investigation score: NA/16 --- ## 1. Computational Deleteriousness In silico predictive frameworks converge on a high probabi...
For RIT1 p.Ala77Thr (small GTPase, NS8), write a research-level variant assessment. The assigned tier is Tier 1 — highest priority and the investigation score is NA/16. Preserve both exactly. Do not make a clinical classification. Include computational deleteriousness, population rarity, structural context within the R...	Variant: RIT1 p.Ala77Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Research-Level Variant Assessment for RIT1 ## Target Variant - Variant: RIT1 p.Ala77Thr - Gene Function: Small GTPase - Associated Condition: NS8 (Noonan Syndrome 8, OMIM 615355) ## Mandatory Constraints 1. Assigned Tier: Tier 1 — highest priority. Preserve this designation exactly. 2. **Inves...	# Research-Level Variant Assessment: RIT1 p.Ala77Thr ## Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1) - Protein Change: p.Ala77Thr - Protein: Small GTPase (219 aa, UniProt Q92963) - Associated Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ## Pipeline Classification Metrics - ...
Explain why RIT1 p.Thr163Ile was assigned to Tier 2 — strong priority. Investigation score: 8/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=29.5 (cadd_phred_final), AlphaMissense score=0.986, AlphaMissense model class=likel...	Variant: RIT1 p.Thr163Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.986 (AlphaMissense ...	# Task: Explain RIT1 Variant Tier Assignment Explain why the variant RIT1 p.Thr163Ile was assigned to Tier 2 — strong priority with an Investigation score: 8/16. ## Constraints - Mandatory Preservation: The assigned tier ("Tier 2 — strong priority") and score ("Investigation score: 8/16") are source-d...	### Variant Assessment: RIT1 p.Thr163Ile Variant: RIT1 p.Thr163Ile Assigned Tier: Tier 2 — strong priority Investigation score: 8/16 --- #### Evidence Summary The prioritization of p.Thr163Ile is supported by a convergence of high-confidence computational predictions, population rarity, and localiza...
Explain the assigned active-investigation tier for RIT1 missense variant p.Ile64Thr. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 10/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Eviden...	Variant: RIT1 p.Ile64Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: high (PHRED 26.2 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.969 (AlphaMissense ...	# Task: Explain the Active-Investigation Tier for RIT1 Variant Analyze and explain the assigned active-investigation tier for the RIT1 missense variant p.Ile64Thr based on the provided evidence. ## Critical Constraints - Preserve Values Exactly: You must include the following values verbatim in your response...	### Variant Analysis: RIT1 p.Ile64Thr Gene: RIT1 (RAS-like without CAAX protein 1) Condition: Noonan Syndrome 8 (NS8, OMIM 615355) Variant: p.Ile64Thr (Missense) Assigned investigation tier: Tier 2 — strong priority Investigation score: 10/16 --- #### Evidence Summary The prioritization ...
Given this RIT1 variant evidence profile — p.Tyr58Asp, assigned tier Tier 1 — highest priority, investigation score 13/16, CADD PHRED 33.0 (cadd_phred_final), AlphaMissense score 0.997, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Tyr58Asp (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 13/16 Evidence profile: - CADD PHRED: very high (PHRED 33.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.997 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose changing it. Variant Evidence Profile: - Variant: p.Tyr58Asp - Assigned Tier: Tier 1 (highest priority) - Investigation Score: 13/16 - CADD PHRED Scor...	Variant: p.Tyr58Asp (RIT1, UniProt Q92963) Evidence Summary The p.Tyr58Asp variant presents a convergent profile of high computational pathogenicity, population absence, and critical structural localization. Key data points: - CADD PHRED: 33.0 (cadd_phred_final; exceeds ≥30 threshold) - **AlphaMissense sco...
Explain why RIT1 p.Leu74Trp was assigned to Tier 1 — highest priority. Investigation score: 12/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=31.0 (cadd_phred_final), AlphaMissense score=0.985, AlphaMissense model class=like...	Variant: RIT1 p.Leu74Trp (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 12/16 Evidence profile: - CADD PHRED: very high (PHRED 31.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.985 (AlphaMis...	# Task: Explain Tier 1 Assignment for RIT1 p.Leu74Trp Provide a detailed explanation for why the variant RIT1 p.Leu74Trp was assigned to Tier 1 (highest priority) with an Investigation score of 12/16. ### Critical Constraints - Verbatim Preservation: You must include the exact phrases "Tier 1" and "In...	### Variant Prioritization Analysis: RIT1 p.Leu74Trp Variant: RIT1 p.Leu74Trp ASSIGNED TIER: Tier 1 Investigation score: 12/16 #### Evidence Summary The assignment of RIT1 p.Leu74Trp to Tier 1 is supported by a convergence of high-confidence computational metrics, absolute population rarity, and local...

End of preview. Expand in Data Studio

This dataset is a remastered version prepared using Adaption's Adaptive Data platform.

adaption-rit1_vus_research_tiers

This dataset contains research-level prioritization assessments for RIT1 missense variants associated with Noonan Syndrome 8 (NS8). Each entry provides a structured analysis including source-derived investigation tiers, scores, and evidence summaries based on computational predictors, population frequency, and structural domain context. The data explicitly preserves pipeline-generated labels for research follow-up while disclaiming clinical classification.

Dataset size

There are 178 data points in this dataset. This is an instruction tuning dataset.

Quality of Remastered Dataset

The final quality is A, with a relative quality improvement of 32.9%.

Domain

Science (73%)
Medical (15%)
Other (12%)

Language

English (100%)

Tone

Technical (89%)
Analytical (12%)

Evaluation Results

Quality Gains:
Grade Improvement:
Percentile Chart:

Downloads last month: 7

prompt stringlengths 426 733	completion stringlengths 3.07k 5.42k	enhanced_prompt stringlengths 597 2.2k	enhanced_completion stringlengths 3.48k 7.54k
Explain the assigned active-investigation tier for RIT1 missense variant p.Thr163Ile. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 8/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Eviden...	Variant: RIT1 p.Thr163Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.986 (AlphaMissense ...	# Task: Explain the Active-Investigation Tier for RIT1 Variant Analyze the provided data for the RIT1 missense variant p.Thr163Ile and explain the rationale behind its assigned investigation tier. ## Critical Constraints - Preserve Values Exactly: You must include the following values verbatim in your respon...	### Variant Analysis: RIT1 p.Thr163Ile Variant: RIT1 p.Thr163Ile (small GTPase, UniProt Q92963) Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355). RIT1 is associated exclusively with NS8; there is no associated CFC syndrome or secondary RASopathy condition for this gene. ASSIGNED TIER: Tier 2 — stro...
Explain the source-derived research-prioritization assessment for RIT1 variant p.Phe82Leu in the context of Noonan Syndrome 8 (NS8, OMIM 615355). Assigned investigation tier: Tier 1 — highest priority. Investigation score: NA/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or ...	Variant: RIT1 p.Phe82Leu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Explain Source-Derived Research-Prioritization Assessment Provide a detailed explanation of the research-prioritization assessment for the RIT1 variant p.Phe82Leu within the context of Noonan Syndrome 8 (NS8, OMIM 615355). ## Critical Constraints - Assigned Investigation Tier: Tier 1 — highes...	# Variant Research Prioritization Assessment: RIT1 p.Phe82Leu ## Variant Identification and Condition Context - Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) - Variant: p.Phe82Leu - Protein: Small GTPase (219 aa) — the shortest protein in the RASopathy VUS series - Associated Condition: ...
Explain why RIT1 p.Asp87His was assigned to Tier 1 — highest priority. Investigation score: 11/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=32.0 (cadd_phred_final), AlphaMissense score=0.993, AlphaMissense model class=like...	Variant: RIT1 p.Asp87His (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 11/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.993 (AlphaMis...	# Task: Explain Tier 1 Assignment for RIT1 p.Asp87His Provide a detailed explanation of why the variant RIT1 p.Asp87His was assigned to Tier 1 (highest priority) with an Investigation score of 11/16. ## Constraints - Mandatory Preservation: You must include the following labels exactly as written, ver...	### Variant Prioritization Assessment: RIT1 p.Asp87His Variant: RIT1 p.Asp87His (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 1 — highest priority Investigation score: 11/16 --- #### Evidence Summary The assignment of RIT1 p.Asp87His to Tier 1 (highest priority) reflects convergence of high...
Given this RIT1 variant evidence profile — p.Ala77Gly, assigned tier Tier 1 — highest priority, investigation score 12/16, CADD PHRED 32.0 (cadd_phred_final), AlphaMissense score 0.973, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Ala77Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 12/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.973 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose any changes to it. Variant Evidence Profile: - Variant: p.Ala77Gly - Assigned Tier: Tier 1 (highest priority) - Investigation Score: 12/16...	Variant: RIT1 p.Ala77Gly (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 1 (highest priority) Investigation Score: 12/16 --- ### Evidence Summary The p.Ala77Gly variant presents a convergent evidence profile warranting highest-priority research investigation within the Noonan Syndrome 8 (NS8, OMIM 61...
Given this RIT1 variant evidence profile — p.Arg183Gly, assigned tier Tier 2 — strong priority, investigation score 10/16, CADD PHRED 33.0 (cadd_phred_final), AlphaMissense score 0.973, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Arg183Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: very high (PHRED 33.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.973 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose any changes to it. Variant Evidence Profile: - Variant: p.Arg183Gly - Assigned Tier: Tier 2 - Priority Level: Strong - **Investigation Sco...	Variant: RIT1 p.Arg183Gly (small GTPase, UniProt Q92963) ASSIGNED TIER: Tier 2 — strong priority Investigation score: 10/16 --- ### Evidence Summary and Research Prioritization Rationale The RIT1 variant p.Arg183Gly is designated Tier 2 — strong priority based on a convergence of high-impact computa...
Explain the assigned active-investigation tier for RIT1 missense variant p.Met90Ile. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 8/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Evidenc...	Variant: RIT1 p.Met90Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.2 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.971 (AlphaMissense m...	Explain the assigned active-investigation tier for the RIT1 missense variant p.Met90Ile based on the provided data. Constraints: - Preserve the following values exactly in your response: - Assigned investigation tier: Tier 2 — strong priority - Investigation score: 8/16 - Do not reclassify, upgrade, downgrad...	Variant Identification Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) Variant: p.Met90Ile Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355) Assigned investigation tier: Tier 2 — strong priority Investigation score: 8/16 --- Evidence Summary The prioritization of RIT1 ...
Given this RIT1 variant evidence profile — p.Ile102Thr, assigned tier Tier 3 — follow-up priority, investigation score 6/16, CADD PHRED 28.8 (cadd_phred_final), AlphaMissense score 0.932, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleter...	Variant: RIT1 p.Ile102Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 3 — follow-up priority Investigation score (source-derived, do not modify): 6/16 Evidence profile: - CADD PHRED: high (PHRED 28.8 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.932 (AlphaMissen...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier (Tier 3) without proposing a change. Variant Evidence Profile: - Variant: p.Ile102Thr - Assigned Tier: Tier 3 - Follow-up Priority: Investigation score 6/...	### Variant Evidence Profile: RIT1 p.Ile102Thr Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1, UniProt Q92963) - Protein Change: p.Ile102Thr - Condition Context: Noonan Syndrome 8 (NS8, OMIM 615355) Evidence Summary The p.Ile102Thr variant presents with elevated computational...
A genetics research team is reviewing RIT1 p.Gly78Glu (small GTPase). Explain why this variant was assigned to Tier 1 — highest priority with investigation score NA/16. The assigned tier and score are source-derived labels and must be preserved verbatim. Summarize CADD PHRED=NA (cadd_phred_final), AlphaMissense score=N...	Variant: RIT1 p.Gly78Glu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Analyze RIT1 Variant Classification You are assisting a genetics research team reviewing the RIT1 p.Gly78Glu variant (a small GTPase). Please explain the rationale for assigning this variant to Tier 1 (highest priority) with an investigation score of NA/16. ## Constraints - **Verbatim Preservation...	# Variant Analysis: RIT1 p.Gly78Glu ## Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1) - Protein Change: p.Gly78Glu - Associated Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ## Assigned Classification and Scores - ASSIGNED TIER: Tier 1 - Investigation score: NA/16 ## Evid...
Explain why RIT1 p.Phe82Leu was assigned to Tier 1 — highest priority. Investigation score: 11/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=31.0 (cadd_phred_final), AlphaMissense score=1.000, AlphaMissense model class=like...	Variant: RIT1 p.Phe82Leu (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 11/16 Evidence profile: - CADD PHRED: very high (PHRED 31.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 1.000 (AlphaMis...	# Task: Explain RIT1 Variant Tier Assignment Explain why the variant RIT1 p.Phe82Leu was assigned to Tier 1 (highest priority) with an Investigation score of 11/16. ### Constraints - Verbatim Preservation: You must preserve the assigned tier and score labels exactly as provided: "Tier 1" and "Investig...	### Variant Assessment: RIT1 p.Phe82Leu Variant: RIT1 p.Phe82Leu (small GTPase, 219 aa, UniProt Q92963) ASSIGNED TIER: Tier 1 Investigation score: 11/16 --- #### Evidence Summary The prioritization of p.Phe82Leu as Tier 1 is supported by convergence of high-impact computational predictions, absolute pop...
Explain the assigned active-investigation tier for RIT1 missense variant p.Met90Thr. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 9/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Evidenc...	Variant: RIT1 p.Met90Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 9/16 Evidence profile: - CADD PHRED: high (PHRED 28.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.996 (AlphaMissense m...	# Task: Explain the Assigned Active-Investigation Tier Analyze the provided data for the RIT1 missense variant p.Met90Thr and explain the rationale behind its assigned investigation tier. ## Critical Constraints - Preserve Values Exactly: You must include the specific tier and score values provided below ver...	### Variant Investigation Report: RIT1 p.Met90Thr Variant: RIT1 missense variant p.Met90Thr ASSIGNED TIER: Tier 2 — strong priority Investigation Score: 9/16 --- ## Evidence Summary The assignment of Tier 2 — strong priority with an Investigation Score: 9/16 reflects a convergence of computa...
Explain why RIT1 p.Asp87Asn was assigned to Tier 2 — strong priority. Investigation score: 10/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=32.0 (cadd_phred_final), AlphaMissense score=0.975, AlphaMissense model class=likel...	Variant: RIT1 p.Asp87Asn (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: very high (PHRED 32.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.975 (AlphaMiss...	# Task: Explain Variant Tier Assignment Explain why the variant RIT1 p.Asp87Asn was assigned to Tier 2 — strong priority with an Investigation score: 10/16. ## Critical Constraints - The assigned tier ("Tier 2 — strong priority") and score ("10/16") are source-derived pipeline labels. You must preserv...	### Variant Tier Assignment Explanation: RIT1 p.Asp87Asn Variant: RIT1 p.Asp87Asn ASSIGNED TIER: Tier 2 — strong priority Investigation score: 10/16 --- #### Evidence Summary The assignment of Tier 2 — strong priority with an Investigation score: 10/16 is based on the convergence of high-imp...
For RIT1 p.Glu81Gly (small GTPase, NS8), write a research-level variant assessment. The assigned tier is Tier 1 — highest priority and the investigation score is NA/16. Preserve both exactly. Do not make a clinical classification. Include computational deleteriousness, population rarity, structural context within the R...	Variant: RIT1 p.Glu81Gly (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Research-Level Variant Assessment Generate a research-level assessment for the variant RIT1 p.Glu81Gly associated with NS8 (Noonan Syndrome 8, OMIM 615355). Note that RIT1 encodes a small GTPase and causes only NS8. ## Mandatory Constraints - Assigned Tier: Tier 1 — highest priority (Preserve this...	# Research-Level Variant Assessment: RIT1 p.Glu81Gly Variant: RIT1 p.Glu81Gly Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ASSIGNED TIER: Tier 1 — highest priority Investigation score: NA/16 --- ## 1. Computational Deleteriousness In silico predictive frameworks converge on a high probabi...
For RIT1 p.Ala77Thr (small GTPase, NS8), write a research-level variant assessment. The assigned tier is Tier 1 — highest priority and the investigation score is NA/16. Preserve both exactly. Do not make a clinical classification. Include computational deleteriousness, population rarity, structural context within the R...	Variant: RIT1 p.Ala77Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): NA/16 Condition context: Noonan Syndrome 8 (NS8, OMIM 615355) research. RIT1 encodes a small GTPase of the RAS superfamily (219 aa), act...	# Task: Research-Level Variant Assessment for RIT1 ## Target Variant - Variant: RIT1 p.Ala77Thr - Gene Function: Small GTPase - Associated Condition: NS8 (Noonan Syndrome 8, OMIM 615355) ## Mandatory Constraints 1. Assigned Tier: Tier 1 — highest priority. Preserve this designation exactly. 2. **Inves...	# Research-Level Variant Assessment: RIT1 p.Ala77Thr ## Variant Identification - Gene: RIT1 (RAS-like without CAAX protein 1) - Protein Change: p.Ala77Thr - Protein: Small GTPase (219 aa, UniProt Q92963) - Associated Condition: Noonan Syndrome 8 (NS8, OMIM 615355) ## Pipeline Classification Metrics - ...
Explain why RIT1 p.Thr163Ile was assigned to Tier 2 — strong priority. Investigation score: 8/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=29.5 (cadd_phred_final), AlphaMissense score=0.986, AlphaMissense model class=likel...	Variant: RIT1 p.Thr163Ile (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 8/16 Evidence profile: - CADD PHRED: high (PHRED 29.5 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.986 (AlphaMissense ...	# Task: Explain RIT1 Variant Tier Assignment Explain why the variant RIT1 p.Thr163Ile was assigned to Tier 2 — strong priority with an Investigation score: 8/16. ## Constraints - Mandatory Preservation: The assigned tier ("Tier 2 — strong priority") and score ("Investigation score: 8/16") are source-d...	### Variant Assessment: RIT1 p.Thr163Ile Variant: RIT1 p.Thr163Ile Assigned Tier: Tier 2 — strong priority Investigation score: 8/16 --- #### Evidence Summary The prioritization of p.Thr163Ile is supported by a convergence of high-confidence computational predictions, population rarity, and localiza...
Explain the assigned active-investigation tier for RIT1 missense variant p.Ile64Thr. Assigned investigation tier: Tier 2 — strong priority. Investigation score: 10/16. Preserve these values exactly in your response. Do not reclassify, upgrade, downgrade, or replace the tier with generic High/Moderate/Low labels. Eviden...	Variant: RIT1 p.Ile64Thr (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 2 — strong priority Investigation score (source-derived, do not modify): 10/16 Evidence profile: - CADD PHRED: high (PHRED 26.2 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.969 (AlphaMissense ...	# Task: Explain the Active-Investigation Tier for RIT1 Variant Analyze and explain the assigned active-investigation tier for the RIT1 missense variant p.Ile64Thr based on the provided evidence. ## Critical Constraints - Preserve Values Exactly: You must include the following values verbatim in your response...	### Variant Analysis: RIT1 p.Ile64Thr Gene: RIT1 (RAS-like without CAAX protein 1) Condition: Noonan Syndrome 8 (NS8, OMIM 615355) Variant: p.Ile64Thr (Missense) Assigned investigation tier: Tier 2 — strong priority Investigation score: 10/16 --- #### Evidence Summary The prioritization ...
Given this RIT1 variant evidence profile — p.Tyr58Asp, assigned tier Tier 1 — highest priority, investigation score 13/16, CADD PHRED 33.0 (cadd_phred_final), AlphaMissense score 0.997, AlphaMissense model class likely pathogenic, absent from gnomAD, GTPase domain (7-208 — catalytic; hardcoded Option B), SIFT deleterio...	Variant: RIT1 p.Tyr58Asp (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 13/16 Evidence profile: - CADD PHRED: very high (PHRED 33.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.997 (AlphaMis...	Analyze the following RIT1 variant evidence profile and explain the research-prioritization rationale. You must strictly adhere to the assigned tier and not propose changing it. Variant Evidence Profile: - Variant: p.Tyr58Asp - Assigned Tier: Tier 1 (highest priority) - Investigation Score: 13/16 - CADD PHRED Scor...	Variant: p.Tyr58Asp (RIT1, UniProt Q92963) Evidence Summary The p.Tyr58Asp variant presents a convergent profile of high computational pathogenicity, population absence, and critical structural localization. Key data points: - CADD PHRED: 33.0 (cadd_phred_final; exceeds ≥30 threshold) - **AlphaMissense sco...
Explain why RIT1 p.Leu74Trp was assigned to Tier 1 — highest priority. Investigation score: 12/16. The assigned tier and score are source-derived pipeline labels and must be preserved verbatim. Use the following evidence only: CADD PHRED=31.0 (cadd_phred_final), AlphaMissense score=0.985, AlphaMissense model class=like...	Variant: RIT1 p.Leu74Trp (small GTPase, Q92963) ASSIGNED TIER (source-derived, do not modify): Tier 1 — highest priority Investigation score (source-derived, do not modify): 12/16 Evidence profile: - CADD PHRED: very high (PHRED 31.0 (cadd_phred_final: API > VEP plugin)) - AlphaMissense score: 0.985 (AlphaMis...	# Task: Explain Tier 1 Assignment for RIT1 p.Leu74Trp Provide a detailed explanation for why the variant RIT1 p.Leu74Trp was assigned to Tier 1 (highest priority) with an Investigation score of 12/16. ### Critical Constraints - Verbatim Preservation: You must include the exact phrases "Tier 1" and "In...	### Variant Prioritization Analysis: RIT1 p.Leu74Trp Variant: RIT1 p.Leu74Trp ASSIGNED TIER: Tier 1 Investigation score: 12/16 #### Evidence Summary The assignment of RIT1 p.Leu74Trp to Tier 1 is supported by a convergence of high-confidence computational metrics, absolute population rarity, and local...